If a P -value of the Egger test was less than 0.05, additional analysis was conducted after excluding the studies that caused asymmetry in the funnel plot
Many Eastern European countries are enhancing healthcare access, particularly for chronic conditions like diabetes
When comparing weight management efficacy per the clinical trials, Wegovy does not offer a version that compares to Zepbounds 7.5 through the 15 milligram doses
This question has gained attention as GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) become increasingly prescribed for type 2 diabetes and weight management
The pattern is predictable: increase the dose on injection day, experience mild nausea for one to three days, notice renewed appetite suppression, and return to baseline comfort within a week
A Comment in @TheLancetEndo discusses the effects of GLP-1 receptor agonists on skeletal muscle mass: hubs.ly/Q02QBfSp0 Therefore #T_Alpha by @biohaven will magic Phase III data for Spinal Muscular Atrophy will have readout this year